These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8609473)

  • 1. Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy.
    Sheehy N; Desselberger U; Whitwell H; Ball JK
    J Gen Virol; 1996 May; 77 ( Pt 5)():1071-81. PubMed ID: 8609473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.
    Ball JK; Holmes EC; Whitwell H; Desselberger U
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():67-79. PubMed ID: 8151287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy.
    Brown AJ; Cleland A
    AIDS; 1996 Sep; 10(10):1067-73. PubMed ID: 8874622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
    Sheehy N; Desselberger U
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random important alterations in HIV-1 viral quasispecies after antiviral treatment.
    Sánchez-Palomino S; Olivares I; Yuste E; Richman DD; López-Galíndez C
    Antivir Ther; 1996 Dec; 1(4):225-36. PubMed ID: 11324825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.
    Kellam P; Boucher CA; Tijnagel JM; Larder BA
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():341-51. PubMed ID: 7509370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
    Kaye S; Comber E; Tenant-Flowers M; Loveday C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stability of human immunodeficiency virus to azidothymidine. II. Kinetic characteristics of "AZT-resistant" mutant forms of reverse transcriptase].
    Pokholok DK; Gudima SO; Memelova LV; Esipov DS; Rechinskiĭ VO; Kochetkov SN
    Biokhimiia; 1996 Jan; 61(1):142-51. PubMed ID: 8679772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients.
    Cleland A; Watson HG; Robertson P; Ludlam CA; Brown AJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):6-18. PubMed ID: 8624762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel mutations that confer drug resistance in the human immunodeficiency virus polymerase gene.
    Gu Z; Gao Q; Fang H; Parniak MA; Brenner BG; Wainberg MA
    Leukemia; 1994 Apr; 8 Suppl 1():S166-9. PubMed ID: 7512178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC.
    Gu Z; Gao Q; Faust EA; Wainberg MA
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2601-5. PubMed ID: 7595365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
    Anderson BD; Shirasaka T; Kojima E; Yarchoan R; Mitsuya H
    Antiviral Res; 1994 Dec; 25(3-4):245-58. PubMed ID: 7710271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
    Muckenthaler M; Gunkel N; Levantis P; Broadhurst K; Goh B; Colvin B; Forster G; Jackson GG; Oxford JS
    J Med Virol; 1992 Feb; 36(2):79-83. PubMed ID: 1374791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Larder BA; Kellam P; Kemp SD
    Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
    Gasmi M; Fillon S; Leriche K; Neisson-Vernant C; Desgranges C
    Antivir Ther; 1997 Apr; 2(2):91-7. PubMed ID: 11322280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.
    Ntemgwa M; Wainberg MA; Oliveira M; Moisi D; Lalonde R; Micheli V; Brenner BG
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3861-9. PubMed ID: 17724152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.